4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-030451
Chairman and CEO bought 23,351 shares at an average $0.41 ($9,573)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-05-09 | Purchase | +6,000 | $0.60 | $3,600 | 11,309,506 | D |
| Niihara Yutaka Chairman and CEO | 2022-05-13 | Purchase | +10,000 | $0.34 | $3,400 | 11,319,506 | D |
| Niihara Yutaka Chairman and CEO | 2022-05-18 | Purchase | +7,351 | $0.35 | $2,573 | 11,326,857 | D |
| Open-market purchases · 23,351 sh · avg $0.41 · $9,573 | |||||||
Loading xslF345X03/doc4.xml…